Esophageal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Esophageal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Chemoradiotherapy of Capecitabine With or Without Oxaliplatin Versus Cisplatin-5-FU for Esophageal Squamous Cancer [Phase 3]
Phase 3 trial comparing capecitabine with or without oxaliplatin to cisplatin-5-FU for esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2023-01-11Clinical Trial Update: Percutaneous Endoscopic Gastrostomy Before Definitive Concurrent Chemoradiation Therapy for Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial update evaluating percutaneous endoscopic gastrostomy before definitive concurrent chemoradiation in esophageal squamous cell …
-
CLINICAL_TRIALS trial_result · 2022-12-14Clinical Trial Update: Camrelizumab Combined With Neoadjuvant Concurrent Chemoradiotherapy for Resectable Locally Advanced ESCC（NICE-RT） [Phase 2]
Phase 2 trial evaluating camrelizumab with neoadjuvant concurrent chemoradiotherapy for resectable locally advanced esophageal squamous cell…
-
CLINICAL_TRIALS trial_result · 2022-12-06Clinical Trial Update: Low Dose Decitabine in Combination With Tirelizumab Comparison of Tirelizumab in the First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial update evaluating low dose decitabine with tirelizumab versus tirelizumab alone as first-line treatment for advanced esophagea…
-
CLINICAL_TRIALS trial_result · 2022-12-05Clinical Trial Update: A Phase II Clinical Study of Fruquintinib Combined With S-1 for Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
Phase II clinical trial evaluating Fruquintinib in combination with S-1 for advanced esophageal squamous cell carcinoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-12-05Clinical Trial Update: Carrelizumab Combined With Chemotherapy for Adjuvant Therapy of Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating carrelizumab in combination with chemotherapy as adjuvant therapy for Esophageal squamous cell carcinoma…
-
CLINICAL_TRIALS trial_result · 2022-11-28Clinical Trial Update: Pembrolizumab and Photodynamic Therapy in Previously Treated Metastatic Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating pembrolizumab combined with photodynamic therapy in previously treated metastatic esophageal squamous cell carcinom…
-
CLINICAL_TRIALS trial_result · 2022-11-28Clinical Trial Update: Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer Patients [Phase 2]
Phase 2 trial update evaluating patient-reported outcomes in preoperative immunochemotherapy/radiotherapy-treated esophageal cancer patients…
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: Moderately Hypofractionated Conformal Radiation Combined With S-1 for Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating moderately hypofractionated conformal radiation with S-1 for esophageal squamous cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: AK104 Plus Concurrent Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial update for AK104 combined with concurrent chemoradiation in esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-10-25Clinical Trial Update: Sintilimab Plus NCT or NCRT Versus NCRT for ESCC [Phase 3]
Phase 3 trial comparing Sintilimab plus NCT or NCRT versus NCRT for Esophageal Squamous Cell Carcinoma is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2022-10-05Clinical Trial Update: Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell Carcinoma [Phase 3]
Phase 3 trial comparing neoadjuvant chemotherapy to surgery alone for esophageal squamous cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-09-29Clinical Trial Update: A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell Cancer [Phase 2]
A multicenter open-label Phase II trial evaluated nivolumab plus ipilimumab as second-line therapy in elderly patients with advanced esophag…
-
CLINICAL_TRIALS trial_result · 2022-09-23Clinical Trial Update: Envafolimab Combined With Chemotherapy in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating Envafolimab in combination with chemotherapy as neoadjuvant therapy for resectable esophageal squamous c…
-
CLINICAL_TRIALS trial_result · 2022-09-21Clinical Trial Update: Efficacy and Safety of Tislelizumab and Nab-paclitaxel Combined With Low-dose Radiotherapy in Patients With Stage IVb Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 study assessing the efficacy and safety of tislelizumab plus nab-paclitaxel with low-dose radiotherapy in stage IVb esophageal squ…
-
CLINICAL_TRIALS trial_result · 2022-09-15Clinical Trial Update: Pembrolizumab Plus CRT Followed by Surgery in Upper ESCC [Phase 1, Phase 2]
Phase 1/2 trial evaluating pembrolizumab with chemoradiotherapy followed by surgery for esophageal squamous cell carcinoma; status currently…
-
CLINICAL_TRIALS trial_result · 2022-08-31Clinical Trial Update: AK104 Alone or in Combination With Chemotherapy in the First-line Treatment of ESCC [Phase 2]
Phase 2 trial exploring AK104 alone or with chemotherapy as first-line treatment for esophageal squamous cell carcinoma (ESCC). Status and r…
-
CLINICAL_TRIALS trial_result · 2022-08-29Clinical Trial Update: A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy or Monotherapy in Patients With Advanced ESCC [Phase 2]
Phase II clinical study evaluating HLX07 combination therapy or HLX07 monotherapy in advanced esophageal squamous cell carcinoma or esophage…
-
CLINICAL_TRIALS trial_result · 2022-08-17Clinical Trial Update: Prospective Trial to Evaluate the Safety and Efficacy to Treat Esophageal Cancer Using 5-FU, Oxaliplatin, and Docetaxel [Phase 2]
A Phase 2 clinical trial is underway to evaluate the safety and efficacy of a chemotherapy regimen (5-FU, oxaliplatin, and docetaxel) for es…
-
CLINICAL_TRIALS trial_result · 2022-08-12Clinical Trial Update: Trastuzumab and Standard Treatment With Chemo- and Immunotherapy as First Line Treatment for HER2 Positive Esophageal Squamous Cell Carcinoma Patients [Phase 2]
Phase 2 trial evaluating trastuzumab with chemo- and immunotherapy as first-line treatment for HER2-positive esophageal squamous cell carcin…
-
CLINICAL_TRIALS trial_result · 2022-08-09Clinical Trial Update: Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903) [Phase 3]
Phase 3 trial comparing neoadjuvant chemotherapy to neoadjuvant chemoradiotherapy for resectable locally advanced esophageal cancer (Esophag…
-
CLINICAL_TRIALS trial_result · 2022-08-05Clinical Trial Update: KN046 in Subjects With Late Stage Esophageal Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial update for KN046 in late-stage esophageal squamous cell carcinoma has completed enrollment and results are likely t…
-
CLINICAL_TRIALS trial_result · 2022-07-27Clinical Trial Update: Neoadjuvant Therapy of Camrelizumab Combined With Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial update of camrelizumab plus chemotherapy as neoadjuvant therapy for resectable locally advanced esophageal squamous cell carci…
-
CLINICAL_TRIALS trial_result · 2022-07-21Clinical Trial Update: Tislelizumab in Combination With Chemotherapy for Conversion Therapy of Locally Nonresectable ESCC [Phase 2]
Phase 2 trial evaluating tislelizumab with chemotherapy for conversion therapy in locally nonresectable esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-07-19Clinical Trial Update: Sintilimab in Combination With Chemotherapy in Neoadjuvant Treatment of Potentially Resectable Esophageal Cancer [Phase 2]
Phase 2 trial update evaluating sintilimab plus chemotherapy as neoadjuvant treatment for potentially resectable esophageal cancer.